The effect of Tylenol on autism risk due to maternal illness during pregnancy [Registered Report Stage 1 Protocol]
ABSTRACTBackground: Tylenol (acetaminophen) is the first line option for managing pain and fever during pregnancy but recent concerns about the risk of autism for the baby have called Tylenol’s safety into question. We propose that epidemiological linkages between Tylenol use and autism arise from the association between illness during pregnancy and autism risk, rather than Tylenol use itself. Methods: Here we directly test the effects of Tylenol on autism related behaviours that are produced by maternal immune activation (MIA) using poly[I:C] in pregnant mice. These include impaired placental function and fetal well-being, reduced ultrasonic vocalizations in mouse pups, reduced sociability in the three-chamber assay and increased marble burying behaviour in juvenile mice. Conclusions: If treatment with Tylenol reduces the effects of MIA while Tylenol alone shows no effect, this study would provide direct evidence that Tylenol is a safe and effective way to manage illness-related symptoms during pregnancy. ITEMSStage 1 Registered Report Protocol
Authors
- Ashlyn Swift‐Gallant (ORCID: https://orcid.org/0000-0001-7224-2672)
- S. Hu
- Lucas F. Fowler (ORCID: https://orcid.org/0009-0001-1051-0149)
- Lindsay Cahill
- Haley Adams
- Shrabontee Deepanwita
- Tevye Stachniak
- Tanya Burry
- Kerri Sparkes
Publication Details
- Journal
- Figshare
- Published
- 2026-11-18
- DOI
- https://doi.org/10.6084/m9.figshare.34930344
- Primary Topic
- Autism Spectrum Disorder Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00